Clinical Trial Update: Monitoring Parameters Beyond Glycemic Control: Impact of Sitagliptin on Quality of Life in Type 2 Diabetes Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating sitagliptin's impact on quality of life in Type 2 diabetes patients, beyond glycemic control.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: Getz Pharma | Conditions: Quality of Life, Type 2 Diabetes | Phase 4 | Status: COMPLETED